MedTrace Logo

Low Dose Computed Tomography for Lung Cancer Screening

NCT03084835 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2019-08-29

No results posted yet for this study

Summary

This study will evaluate the impact of a proactive, EHR-supported enrollment strategy that links LDCT-eligible smokers with an evidence-based intervention comprised of a web-based program and integrated text messaging. The goal is to provide actionable findings about how to most effectively and cost efficiently promote abstinence in LDCT clinics.

Conditions

  • Smoking

Interventions

BEHAVIORAL

Usual Care

Brief cessation counseling

BEHAVIORAL

WEB+TXT

Access to Become an Ex website plus text messaging

BEHAVIORAL

WEB+TXT+TTS

Access to Become an Ex website plus text messaging plus consult with a trained tobacco treatment specialist

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Truth Initiative

    collaborator OTHER

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • James T Hays, MD · Mayo Clinic

  • David E Midthun, MD · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-08-14
Primary Completion
2019-04-30
Completion
2019-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03084835 on ClinicalTrials.gov